Genetic regulation of MUC1 alternative splicing in human tissues

Br J Cancer. 2008 Sep 16;99(6):978-85. doi: 10.1038/sj.bjc.6604617.

Abstract

The membrane mucin MUC1 is aberrantly expressed in a variety of cancers, and in stomach, it is a ligand for Helicobacter pylori where it plays a role in gastric carcinogenesis. Splicing variation, leading to a 9-amino acid insertion in the signal peptide region, was proposed to be because of a single-nucleotide polymorphism (rs4072037) at the 5' end of exon 2, but is also reported to be cancer-associated. However, the effect of rs4072037 on this splicing event in healthy non-cancer tissues and on the additional spliceoforms ofMUC1, including those lacking the polymorphic tandem repeat (TR) domain, has never been investigated. Here we show that in both foetal and adult tissues of known genotype, there is clear evidence for the role of rs4072037 in controlling alternative splicing of the 5' exon 2 region of both full-length transcripts and those lacking the TR domain. Although there is some evidence for additional genetic and epigenetic influences, there is no indication of an effect of the TR domain on the proportions of the spliceoforms. In conclusion, over-representation of certain transcripts in tumour material cannot be evaluated without information on the SNP genotype as well.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Alternative Splicing*
  • Blotting, Southern
  • Exons / genetics
  • Fetus
  • Gene Expression Regulation / physiology*
  • Humans
  • Mucin-1 / genetics*
  • Polymorphism, Single Nucleotide*
  • Tandem Repeat Sequences / genetics
  • Tissue Distribution

Substances

  • MUC1 protein, human
  • Mucin-1